Abstract
Objectives: Cultured endothelial progenitor cells (EPCs) display troubling issues that adversely affect their applicability to endothelial regeneration. We hypothesized that transduction of the human telomerase catalytic subunit (hTERT) gene would enhance EPC function in treating dietary-induced early atherosclerosis (AS). Methods: A dietary-induced early AS model was successfully constructed in 90 healthy male rats, while 30 healthy control (HC) rats were normally fed. Four experimental groups were constructed: an untreated HC group; an untreated AS group injected with PBS; a null EPC AS group injected with null vector-transduced EPCs, and an hTERT EPC AS group injected with hTERT-transduced EPCs. Two months postinjection, abdominal aortas were extracted to validate EPC integration and comparatively assess mRNA and protein expression of the early atherosclerotic markers VCAM-1, ICAM-1, LFA-1, Mac-1, CD44, MCP-1, endothelial nitric oxide synthase (eNOS), and apolipoprotein E. Results: In vitro, hTERT transduction of EPCs resulted in a significantly superior proliferative capacity as well as significantly higher NO, iNOS, and LDH secretory capacity. In vivo injection of hTERT-transduced EPCs produced significant reductions in CD44 and MCP-1 expression as well as a significant increase in eNOS expression relative to injection with null vector-transduced EPCs (all p < 0.05). Conclusion: hTERT-transduced human EPCs may be useful in treating dietary-induced early AS.
Journal Section:
Editor's choice
References
1.
Matsuzawa Y, Guddeti RR, Kwon T-G, Lerman LO, Lerman A: Secondary prevention strategy of cardiovascular disease using endothelial function testing. Circ J 2015;79:685-694.
[PubMed]
2.
Choi B-J, Matsuo Y, Aoki T, Kwon T-G, Prasad A, Gulati R, Lennon RJ, Lerman LO, Lerman A: Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis. Arterioscler Thromb Vasc Biol 2014;34:2473-2477.
[PubMed]
3.
Tousoulis D, Psaltopoulou T, Androulakis E, Papageorgiou N, Papaioannou S, Oikonomou E, Synetos A, Stefanadis C: Oxidative stress and early atherosclerosis: novel antioxidant treatment. Cardiovasc Drugs Ther 2015;29:75-88.
[PubMed]
4.
Dimmeler S, Zeiher AM: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 2004;82:671-677.
[PubMed]
5.
Li S-H, Wang D-D, Xu Y-J, Ma G-D, Li X-Y, Liang W-J: Exogenous hTERT gene transfected endothelial progenitor cells from bone marrow promoted angiogenesis in ischemic myocardium of rats. Int J Clin Exp Med 2015;8:14447.
[PubMed]
6.
Ma Y, Malbon CC, Williams DL, Thorngate FE: Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein e. PLoS One 2008;3:e2503.
[PubMed]
7.
Wang F, Xue J, Wang D, Wang X, Lu S, Tan M: Treatment of atherosclerosis by transplantation of bone endothelial progenitor cells over-expressed paraoxonase-1 gene by recombinant adeno-associated virus in rat. Biol Pharm Bull 2010;33:1806-1813.
[PubMed]
8.
Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-3427.
[PubMed]
9.
Yuan JS, Reed A, Chen F, Stewart CN: Statistical analysis of real-time PCR data. BMC Bioinformatics 2006;7:1.
[PubMed]
10.
Lei H, Romeo G, Kazlauskas A: Heat shock protein 90α-dependent translocation of annexin II to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta. Circ Res 2004;94:902-909.
[PubMed]
11.
Rader DJ, Daugherty A: Translating molecular discoveries into new therapies for atherosclerosis. Nature 2008;451:904-913.
[PubMed]
12.
Butcher MJ, Galkina E: Mechanisms of Leukocyte Recruitment into the Aorta during Atherosclerosis. Rijeka, InTech, 2012.
13.
Krettek A, Sjoberg S: CD44 - a new cardiovascular drug target or merely an innocent bystander? Cardiovasc Haematol Disord Drug Targets 2009;9:293-302.
[PubMed]
14.
Xiao H-B, Lu X-Y, Sun Z-L, Zhang H-B: Kaempferol regulates OPN-CD44 pathway to inhibit the atherogenesis of apolipoprotein E deficient mice. Toxicol Appl Pharmacol 2011;257:405-411.
[PubMed]
15.
Zhao L, Hall JA, Levenkova N, Lee E, Middleton MK, Zukas AM, Rader DJ, Rux JJ, Puré E: CD44 regulates vascular gene expression in a proatherogenic environment. Arterioscler Thromb Vasc Biol 2007;27:886-892.
[PubMed]
16.
Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ: The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 2001;108:1031.
[PubMed]
17.
Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138.
[PubMed]
18.
Kowala MC, Recce R, Beyer S, Gu C, Valentine M: Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 2000;149:323-330.
[PubMed]
19.
Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K: Early human atherosclerosis accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007;27:1159-1165.
[PubMed]
20.
Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281.
[PubMed]
21.
Cybulsky MI, Marsden PA: Effect of disturbed blood flow on endothelial cell gene expression a role for changes in RNA processing. Arterioscler Thromb Vasc Biol 2014;34:1806-1808.
[PubMed]
22.
Heo K-S, Fujiwara K, Abe J: Shear stress and atherosclerosis. Mol Cells 2014;37:435.
[PubMed]
23.
Heo K-S, Berk B, Abe J: Disturbed flow-induced endothelial proatherogenic signaling via regulating post-translational modifications and epigenetic events. Antioxid Redox Signal 2016, Epub ahead of print.
[PubMed]
24.
Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T: Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 1996;271:6518-6522.
[PubMed]
25.
Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Lüscher TF: Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998;97:2494-2498.
[PubMed]
26.
Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA: Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.
[PubMed]
© 2016 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2016
You do not currently have access to this content.
